Cognizant Collaborates with Medidata to Provide Specialized Support for Life Sciences Clients
Cognizant (CTSH) has announced an expanded partnership with Medidata, a Dassault Systèmes brand specializing in clinical trial solutions. The multi-year renewal agreement focuses on providing enhanced support for Medidata's life sciences clients through a dedicated team of platform specialists serving pharmaceutical, biotech, medical device, and contract research organizations.
The collaboration aims to maximize Medidata's value proposition by improving user satisfaction and streamlining clinical trial development. Key aspects include customer success, patient service desk, implementation, engineering, integrations, and user acceptance testing services. The partnership will leverage Medidata's AI-powered technologies, including Clinical Data Studio, Health Record Connect, and myMedidata patient portal, combined with Cognizant's network of Medidata Certified Services Professionals.
Cognizant (CTSH) ha annunciato un'espansione della partnership con Medidata, un marchio di Dassault Systèmes specializzato nelle soluzioni per le sperimentazioni cliniche. L'accordo di rinnovo pluriennale si concentra sulla fornitura di un supporto avanzato per i clienti di Medidata nel settore delle scienze della vita, attraverso un team dedicato di specialisti della piattaforma che supporta aziende farmaceutiche, biotech, dispositivi medici e organizzazioni di ricerca contrattuale.
La collaborazione mira a massimizzare la proposta di valore di Medidata migliorando la soddisfazione degli utenti e ottimizzando lo sviluppo delle sperimentazioni cliniche. Tra gli aspetti chiave ci sono il successo del cliente, il desk di supporto per i pazienti, l'implementazione, ingegneria, integrazioni e servizi di test di accettazione da parte degli utenti. La partnership sfrutterà le tecnologie potenziate dall'AI di Medidata, tra cui Clinical Data Studio, Health Record Connect e il portale paziente myMedidata, combinandole con la rete di professionisti certificati Medidata di Cognizant.
Cognizant (CTSH) ha anunciado una ampliación de la asociación con Medidata, una marca de Dassault Systèmes que se especializa en soluciones para ensayos clínicos. El acuerdo de renovación por varios años se centra en proporcionar un apoyo mejorado a los clientes de Medidata en ciencias de la vida a través de un equipo dedicado de especialistas en la plataforma que sirven a organizaciones farmacéuticas, biotecnológicas, de dispositivos médicos y de investigación por contrato.
La colaboración tiene como objetivo maximizar la propuesta de valor de Medidata al mejorar la satisfacción del usuario y optimizar el desarrollo de ensayos clínicos. Los aspectos clave incluyen el éxito del cliente, el servicio de atención al paciente, la implementación, la ingeniería, las integraciones y los servicios de pruebas de aceptación del usuario. La asociación aprovechará las tecnologías impulsadas por AI de Medidata, incluidos Clinical Data Studio, Health Record Connect y el portal del paciente myMedidata, combinadas con la red de profesionales certificados de Medidata en Cognizant.
코그니전트 (CTSH)가 임상 시험 솔루션을 전문으로 하는 다소 소프트웨어의 브랜드인 메디데이터와의 파트너십을 확대했다고 발표했습니다. 다년간의 갱신 계약은 제약, 생명공학, 의료기기 및 계약 연구 조직을 위해 플랫폼 전문가 전담 팀을 통해 메디데이터의 생명 과학 고객에 대한 향상된 지원 제공에 중점을 두고 있습니다.
이번 협업은 사용자 만족도를 개선하고 임상 시험 개발을 간소화하여 메디데이터의 가치 제안을 극대화하는 것을 목표로 합니다. 주요 사항으로는 고객 성공, 환자 서비스 데스크, 구현, 엔지니어링, 통합 및 사용자 수용 테스트 서비스가 있습니다. 이 파트너십은 Clinical Data Studio, Health Record Connect 및 myMedidata 환자 포털을 포함한 메디데이터의 AI 기반 기술을 활용하며, 코그니전트의 메디데이터 인증 서비스 전문가 네트워크와 결합됩니다.
Cognizant (CTSH) a annoncé un partenariat élargi avec Medidata, une marque de Dassault Systèmes spécialisée dans les solutions d'essai clinique. L'accord de renouvellement pluriannuel se concentre sur la fourniture d'un support amélioré pour les clients de Medidata dans les sciences de la vie grâce à une équipe dédiée de spécialistes de la plateforme servant les entreprises pharmaceutiques, biotechnologiques, de dispositifs médicaux et d'organisations de recherche sous contrat.
La collaboration vise à maximiser la proposition de valeur de Medidata en améliorant la satisfaction des utilisateurs et en rationalisant le développement des essais cliniques. Les aspects clés comprennent le succès des clients, le service d'assistance aux patients, la mise en œuvre, l'ingénierie, les intégrations et les services de tests d'acceptation des utilisateurs. Le partenariat tirera parti des technologies alimentées par l'IA de Medidata, y compris Clinical Data Studio, Health Record Connect et le portail patient myMedidata, combiné au réseau de professionnels certifiés Medidata de Cognizant.
Cognizant (CTSH) hat eine erweiterte Partnerschaft mit Medidata angekündigt, einer Marke von Dassault Systèmes, die auf klinische Studienlösungen spezialisiert ist. Die mehrjährige Erneuerungsvereinbarung konzentriert sich darauf, Medidatas Kunden im Bereich der Lebenswissenschaften durch ein dediziertes Team von Plattform-Spezialisten zu unterstützen, das für pharmazeutische Unternehmen, Biotechnologie, medizinische Geräte und Auftragsforschungsorganisationen tätig ist.
Die Zusammenarbeit zielt darauf ab, Medidatas Wertangebot zu maximieren, indem die Benutzerzufriedenheit verbessert und die Entwicklung klinischer Studien vereinfacht wird. Wichtige Aspekte sind der Kundenerfolg, der Patientenservicedesk, Implementierung, Ingenieurwissenschaften, Integrationen und Dienstleistungen zur Benutzerakzeptanzprüfung. Die Partnerschaft wird Medidatas KI-gestützte Technologien nutzen, darunter Clinical Data Studio, Health Record Connect und das Patientenvolumen myMedidata, kombiniert mit dem Netzwerk von Medidata-zertifizierten Dienstleistungsexperten von Cognizant.
- Strategic expansion of partnership with industry leader Medidata strengthens Cognizant's position in life sciences sector
- Multi-year renewal agreement provides stable, long-term revenue stream
- Access to advanced AI-powered technologies enhances service offerings
- None.
Insights
The expanded partnership between Cognizant and Medidata marks a significant strategic advancement in the $50+ billion clinical trials technology market. This collaboration strengthens Cognizant's position in the lucrative life sciences technology sector through several key mechanisms:
The partnership leverages three critical market trends: 1) The increasing demand for AI-powered clinical trial solutions, 2) The growing need for integrated clinical data management platforms and 3) The industry-wide push for improved trial efficiency and patient outcomes. By providing dedicated Medidata Platform specialists and expanding access to AI-powered technologies, Cognizant positions itself to capture a larger share of the clinical trial technology services market.
The multi-year renewal agreement has particular significance in the context of rising R&D costs in the pharmaceutical industry, where clinical trials typically account for 40-60% of R&D budgets. By offering comprehensive support services - from implementation to user acceptance testing - Cognizant establishes recurring revenue streams while deepening its relationship with life sciences clients.
The focus on Medidata's advanced platforms, including Clinical Data Studio and Health Record Connect, aligns with the industry's digital transformation trajectory. This positions Cognizant advantageously in the rapidly growing market for AI-enabled clinical trial solutions, expected to grow at a CAGR of 15-20% through 2028.
The organizations plan to support clients through expanded partnership and offer broader access to Medidata's AI-powered technologies to accelerate clinical trial development
As part of the multi-year renewal agreement, Cognizant is providing a dedicated team of Medidata Platform specialists to support their clients in pharmaceutical, biotech, medical device, contract research organizations, and patients using Medidata services. The goal is to maximize Medidata's value for life sciences clients. The collaboration aims to improve the experience for Medidata's users, enabling their clients to focus on clinical trial development and improving patient outcomes.
"Our partnership with Cognizant represents a shared commitment to transforming clinical research through innovation and expertise," said Janet Butler, EVP, Head of Global Sales, of Medidata. "By combining Medidata's advanced AI-driven technologies with Cognizant's deep industry knowledge and operational excellence, we support life sciences organizations to streamline their R&D efforts, derive actionable insights from complex data, and ultimately bring life-changing therapies to patients more efficiently."
Cognizant and Medidata are deepening their multi-year collaboration with the goal to accelerate clinical trial development by expanding access to Medidata's AI-powered technologies. When combined with Medidata Clinical Data Studio, Medidata Health Record Connect, and the myMedidata patient portal, these solutions are helping to transform R&D with tailored patient, site, and data experiences. As a top Global Medidata Strategic Alliance Partner, Cognizant is leveraging its extensive network of Medidata Certified Services Professionals to help life sciences organizations modernize clinical operations and data management.
"We are thrilled to accelerate our work with Medidata to help mutual clients leverage next-generation AI-enabled clinical capabilities on the unified Medidata Platform," said Mohammad Haque, SVP, Global Large Deals Lead and Business Unit Head, Life Sciences, of Cognizant. "Our collaboration aims to unlock the full potential of clients' clinical data and processes, improving user satisfaction and empowering them to make better-informed decisions faster for improved patient outcomes."
About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life. See how at www.cognizant.com or @cognizant.
For more information, contact:
Natalie Steffen
Natalie.Steffen@cognizant.com
300 Frank W. Burr Blvd. Suite 36, 6th Floor
+1 201 801 0233 Cognizant.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cognizant-collaborates-with-medidata-to-provide-specialized-support-for-life-sciences-clients-302363839.html
SOURCE Cognizant Technology Solutions Corporation
FAQ
What is the purpose of Cognizant's expanded partnership with Medidata?
What services will CTSH provide under the new agreement?
How will this partnership benefit Medidata's clients?
What specific Medidata technologies will be utilized in this partnership?
How will CTSH support Medidata's platform implementation?
